Ceribell (CBLL) Revenue Growth (1y) (2024 - 2026)
Ceribell (CBLL) Revenue Growth (1y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.00 Bn | 175.71 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.69 Bn | 125.81 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.39 Bn | 66.93 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 47.97 Bn | 44.30 Bn | 1.29 Bn | 16.70% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.00 Bn | 1.98 Bn | 7.41% |
| 7 | Dexcom | 28.21 Bn | 27.09 Bn | 750.30 Mn | 15.05% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 6.08% |
| 10 | Ceribell | 665.70 Mn | 524.51 Mn | 23.12 Mn | 29.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.30% |
| Dec 31, 2025 | 33.72% |
| Sep 30, 2025 | 31.37% |
| Jun 30, 2025 | 38.42% |
| Mar 31, 2025 | 42.30% |
| Dec 31, 2024 | 41.15% |
| Sep 30, 2024 | 48.09% |